Clinical Performance of Adhesive Systems Containing HEMA and 10-MDP in Non Carious Cervical Lesions

NCT ID: NCT04756349

Last Updated: 2022-05-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-12

Study Completion Date

2022-02-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this randomized, double-blind clinical trial is to evaluate the clinical performance of non-carious cervicals adhesive restorations using three self-etching adhesives containing HEMA and 10-MDP monomers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sixty teeth (n = 20 for each group) will be randomized into 03 groups: Clearfil SE (contains MDP and HEMA), Optibond All-inOne (contains HEMA) and Prime and Bond Universal (contains neither monomer) dispatch). Restorations will be performed by a single operator, and no mechanical retention will be performed under the cavity. After 6, 12 and 24 months, the restorations will be evaluated by two calibrated examiners, using modified USPHS criteria for retention (kappa = 1.00) and adaptation / marginal color (kappa = 0.81), and the results will be analysed by Fisher and Kruskal-Wallis, respectively. An intragroup analysis will be performed using the Cochran test (for retention) and Wilcoxon (for marginal adaptation / staining).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non Carious Cervical Lesion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Clearfil SE

Group containing 10-MDP and HEMA monomers

Group Type ACTIVE_COMPARATOR

composite resin restoration

Intervention Type OTHER

All patients will receive adhesive composite resin restorations. There will be 3 groups (different adhesives): Clearfil SE, Optibond All-in-One and Prime \& Bond Universal.

Optibond All-in-One

Group containing HEMA monomer

Group Type ACTIVE_COMPARATOR

composite resin restoration

Intervention Type OTHER

All patients will receive adhesive composite resin restorations. There will be 3 groups (different adhesives): Clearfil SE, Optibond All-in-One and Prime \& Bond Universal.

Prime & Bond Universal

Control Group containing other monomers

Group Type ACTIVE_COMPARATOR

composite resin restoration

Intervention Type OTHER

All patients will receive adhesive composite resin restorations. There will be 3 groups (different adhesives): Clearfil SE, Optibond All-in-One and Prime \& Bond Universal.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

composite resin restoration

All patients will receive adhesive composite resin restorations. There will be 3 groups (different adhesives): Clearfil SE, Optibond All-in-One and Prime \& Bond Universal.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

composite resin restorations with Clearfil SE adhesive composite resin restorations with Optibond All-in-One adhesive composite resin restorations with Prime & Bond Universal adhesive

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Good oral hygiene
* Absence of periodontal disease
* Presence of at least 02 non-carious cervical lesions

Exclusion Criteria

* Presence of non-carious cervical lesion in non-vital teeth
* Occlusal instability
* Presence of orthodontic appliance
* Presence of removable partial dental prosthesis
* High risk of caries (presence of three or more active caries lesions)
* Xerostomia
* Bruxism
* Patients allergic to base materials monomers
* Patients who do not accept the project conditions
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidade Federal do Para

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cecy Martins Silva

Clinical professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Roberta Oliveira, Msc

Role: PRINCIPAL_INVESTIGATOR

Federal University of Pará

Brennda De Paula, Msc

Role: STUDY_CHAIR

Federal University of Pará

Cecy Silva, PhD

Role: STUDY_DIRECTOR

Federal University of Pará

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Para's Federal University

Belém, Pará, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UFPara

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.